Enable Injections
Cincinnati, Ohio, United States · Healthcare, Health Care, Manufacturing · 435 employees
Enable Injections is a Cincinnati-based global healthcare innovation company that develops and manufactures advanced drug delivery systems designed to improve the patient experience. Its body-worn enFuse® platform enables the subcutaneous delivery of large-volume therapeutics, enhancing convenience while potentially supporting improved safety outcomes and more efficient healthcare system economics
Funding history
- Funding Round — $30.0M — Jan 2026
- Funding Round — $150.0M — Feb 2022
- Funding Round — $215.0M — Jan 2022
- Funding Round — $30.7M — Oct 2018
- Funding Round — $25.0M — Nov 2016
Recent signals
- Jan 09, 2026: Raised $30.0M
- May 22, 2024: Enable Injections, Inc. Appoints Matthew Huddleston as Chief Commercial Officer
- Feb 07, 2024: Enable Injections Appoints David Kroekel as Chief Operating Officer
- Feb 03, 2022: Raised $150.0M
- Jan 27, 2022: Raised $215.0M
- Oct 30, 2018: Raised $30.7M
- Nov 17, 2016: Raised $25.0M
- Sep 01, 2016: Raised $10.0M
See plans & pricing → Track Enable Injections’s funding, hiring, and signals — with verified contacts — on Fundz.